Risk stratification with the risk chart from the European Society of Hypertension compared with SCORE in the general population

Journal of Hypertension

Volumn 27, Issue 12, 2009, Pages 2351-2357

  Sehestedt, Thomas ^a,b   Jeppesen, Jorgen ^a,c   Hansen, Tine W ^b,d   Rasmussen, Susanne ^e   Wachtell, Kristian ^f   Ibsen, Hans ^g   Torp Pedersen, Christian ^c,e   Olsen, Michael H ^a,c  

^a GLOSTRUP UNIVERSITY HOSPITAL   (Denmark)

^b Research Centre for Prevention and Health   (Denmark)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

^d HVIDOVRE HOSPITAL   (Denmark)

^e GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^f Rigshospitalet   (Denmark)

^g HOLBÆK HOSPITAL   (Denmark)

Author keywords

Albuminuria; Atherosclerotic plaques; Left ventricular hypertrophy; Population sample; Prognosis; Pulse wave velocity; Risk factors; Risk stratification; SCORE; Subclinical organ damage

Indexed keywords

ADULT; ARTICLE; CLINICAL ASSESSMENT TOOL; CONTROLLED STUDY; EUROPEAN SOCIETY OF HYPERTENSION RISK CHART; FEMALE; HUMAN; HYPERTENSION; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; RISK FACTOR; SYSTEMIC CORONARY RISK EVALUATION;

EID: 73649134375     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/HJH.0b013e328330e90a     Document Type: Article

References (28)

1. Maneia G, De BG, Dominiczak A, Cifkova R, Fagard R, Germano G, et al. 2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2007; 26:1105-1187.
2. Conroy RM, Pyorala K, Fitzgerald AP, Sans S, Menotti A, De BG, et al. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J 2003; 24:987-1003. (Pubitemid 36712275)
3. JensenJS,Feldt-RasmussenB,StrandgaardS,SchrollM,Borch-JohnsenK. Arterialhypertension,microalbuminuria,andriskofischemicheartdisease. Hypertension2000;35:898-903.(Pubitemid30303947)
4. Olsen MH, Wachtell K, Bella JN, Palmieri V, Gerdts E, Smith G, et al. Albuminuria predicts cardiovascular events independently of left ventricular mass in hypertension: a LIFE substudy. J Hum Hypertens 2004; 18:453-459. (Pubitemid 38787041)
5. Laurent S, Boutouyrie P, Asmar R, Gautier I, Laloux B, Guize L, et al. Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients. Hypertension 2001; 37:1236-1241.
6. Mattace-Raso FU, van der Cammen TJ, Hofman A, van Popele NM, Bos ML, Schalekamp MA, et al. Arterial stiffness and risk of coronary heart disease and stroke: the Rotterdam study. Circulation 2006; 113:657-663. (Pubitemid 43754329)
7. LevyD,GarrisonRJ,SavageDD,KannelWB,CastellWP. PrognosticImplicationsofeohocardiographicallydeterminedleftventricularmassinthe FraminghamHeartStudy.WEnglJMed1990;322:1561-1566.(Pubitemid20176696)
8. SchillaciG,VerdecchiaP,PoroellatiC,CuccurulloO,CoscoC,PerticoneF. Continuousrelationbetweenleftventricularmassandcardiovascularriskinessentialhy pertension.Hypertension2000;36:580-586.(Pubitemid30108152)
9. O'Leary DH, Polak JF, Kronmal RA, Manolio TA, Burke GL, Wolfson SK Jr. Carotid-artery Intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group. N Engl J Med 1999; 340:14-22.
10. Schiller NB, Shah PM, Crawford M, DeMaria A, Devereux R, Feigenbaum H, et al. Recommendations for quantitation of the left ventricle by twodimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of TwoDimensional Echocardiograms. J Am Soc Echocardiogr 1989; 2:358-367.
11. Hansen TW, Jeppesen J, Rasmussen S, Ibsen H, Torp-Pedersen C. Relation between insulin and aortic stiffness: a population-based study. J Hum Hypertens 2004; 18:1-7. (Pubitemid 38165515)
12. RoweDJ,DawnayA,WattsGF.Microalbuminuriaindiabetesmellitus: reviewandrecommendationsforthemeasurementofalbumininurine.AnnClinBiochem1990; 27(Pt4):297-312.(Pubitemid20210076)
13. Madsen M, Davidsen M, Rasmussen S, Abildstrom SZ, Osier M. The validity of the diagnosis of acute myocardial Infarction In routine statistics: a comparison of mortality and hospital discharge data with the Danish MONICA registry. J Clin Epidemiol 2003; 56:124-130. (Pubitemid 36315938)
14. Ian Graham. Cardiovascular disease prevention in clinical practice. In: Vahanlan A, editor. Compendium of abridged ESC guidelines. London: Lippincott Williams and Wilkins; 2008. pp. 3-15.
15. Somes G. McNemar test. In: Kotz S, Johnson N, editors. Encyclopedia of statistical sciences. New York: Wiley; 1983. vol.5, pp. 361-363.
16. Bhapkar VP. On the analysis of contingency tables with a quantitative response. Biometrics 1968; 24:329-338.
17. Newcombe RG. Two-sided confidence intervals for the single proportion: comparison of seven methods. Stat Med 1998; 17:857-872. (Pubitemid 28185165)
18. WilsonPW,D'AgostinoRB,LevyD,BelangerAM,SilbershatzH,KannelWB. Predictionofcoronaryheartdiseaseusingriskfactorcategories.Circulation1998;97: 1837-1847.(Pubitemid28213628)
19. Lengele JP, Vinck WJ, De Plaen JF, Persu A. Cardiovascular risk assessment in hypertensive patients: major discrepancy according to ESH and SCORE strategies. J Hypertens 2007; 25:757-762. (Pubitemid 46402865)
20. Leoncini G, Ratto E, Viazzi F, Conti N, Falqui V, Parodi A, et al. Global risk stratification in primary hypertension: the role of the kidney. J Hypertens 2008; 26:427-432. (Pubitemid 351317250)
21. Viazzi F, Parodi D, Leoncini G, Vettoretti S, Ratto E, Vaccaro V, ef al. Optimizing global risk evaluation In primary hypertension: the role of microalbuminuria and cardiovascular ultrasonography. J Hypertens 2004; 22:907-913.
22. Arnlov J, Evans JC, Meigs JB, Wang TJ, Fox CS, Levy D, et al. Low-grade albuminuria and incidence of cardiovascular disease events in nonhypertensive and nondiabetic individuals: the Framingham Heart Study. Circulation 2006; 112:969-975.
23. Lawes CM, Vander HS, Rodgers A. Global burden of blood-pressurerelated disease, 2001. Lancet 2008; 371:1513-1518.
24. Ibsen H, Olsen MH, Wachtell K, Borch-Johnsen K, Lindholm LH, Mogensen CE, et al. Reduction in albuminuria translates to reduction in cardiovascular events in hypertensive patients: losartan intervention for endpoint reduction in hypertension study. Hypertension 2005; 45:198-202. (Pubitemid 40179960)
25. Donnelly R, Rea R. Microalbuminuria: how Informative and reliable are Individual measurements? J Hypertens 2003; 21:1229-1233. (Pubitemid 36930222)
26. Olsen MH, Hansen TW, Christensen MK, Gustafsson F, Rasmussen S, Wachtell K, et al. N-terminal pro-brain natriuretic peptide, but not high sensitivity C-reactive protein, improves cardiovascular risk prediction in the general population. Eur Heart J 2007; 28:1374-1381.
27. Asmar R, Benetos A, Topouchian J, Laurent P, Pannier B, Brisac AM, et al. Assessment of arterial distensibility by automatic pulse wave velocity measurement. Validation and clinical application studies. Hypertension 1995;26:485-490.
28. Vasan RS, Larson MG, Leip EP, Evans JC, O'Donnell CJ, Kannel WB, et al. Impact of high-normal blood pressure on the risk of cardiovascular disease. N Engl J Med 2001; 345:1291-1297.